Pfizer is a venerable pharmaceutical company with a wide variety of existing products and a solid drug pipeline, whereas Moderna is more of a one-trick pony, having no revenues to speak of before it ...
On Tuesday, Pfizer Inc. (NYSE:PFE) reported second-quarter adjusted EPS of $0.60, down 11% year over year, beating the consensus of $0.46. The U.S. drugmaker reported sales of $13.28 billion, up 2% ...
Pfizer's revenues were declining prior to the pandemic, but the success of its COVID vaccine and antiviral brought in unexpected additional revenues of >$55bn over 2 years. The company has been on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results